Form 4: Thermopylae Holdings Donates ABCL Shares

Thermopylae Holdings Ltd., a 10% owner and director of AbCellera Biologics Inc., reported a charitable donation of 225,000 common shares.

Summary

• Thermopylae Holdings Ltd., identified as a Director and 10% Owner of AbCellera Biologics Inc. (ABCL), filed a Statement of Changes in Beneficial Ownership (Form 4).
• On December 18, 2025, Thermopylae Holdings Ltd. completed a charitable donation of 225,000 common shares of AbCellera Biologics Inc.
• The shares were disposed of at a price of $0 per share, consistent with a donation.
• Following this transaction, Thermopylae Holdings Ltd. beneficially owns 55,918,640 common shares of AbCellera Biologics Inc.

Sentiment

Score: 5

Explanation: The filing reports a charitable donation of shares by a significant shareholder, which is a neutral event regarding the company's operational performance or financial health. It represents a change in beneficial ownership rather than a strategic or financial announcement.

Positives

• No direct positive financial impact on the company's operations or valuation is indicated by this insider transaction.

Negatives

• The transaction represents a reduction in direct beneficial ownership by a significant shareholder, Thermopylae Holdings Ltd., by 225,000 common shares. However, the overall holding remains substantial at 55,918,640 shares.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding AbCellera Biologics Inc.'s operations or financial performance.

Industry Context

This Form 4 filing reports an insider transaction and does not provide information related to broader industry trends or competitors. It reflects a change in beneficial ownership by a significant shareholder of AbCellera Biologics Inc., a biotechnology company focused on antibody discovery.

Comparison to Industry Standards

• This filing is a standard insider transaction report (Form 4) and does not contain information that allows for a direct comparison of company results to global benchmarks or specific comparable companies/projects. It solely details a change in beneficial ownership by a director and 10% owner.

Related Party Transactions

• Thermopylae Holdings Ltd., a 10% owner and director of AbCellera Biologics Inc., made a charitable donation of 225,000 common shares on December 18, 2025.

Stakeholder Impact

• Shareholders: A minor reduction in direct beneficial ownership by a significant shareholder (Thermopylae Holdings Ltd.), though the overall holding remains substantial.

Key Dates

Recommendation

The filing reports a charitable donation of shares by a significant shareholder, Thermopylae Holdings Ltd. This is a routine insider transaction and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The shareholder retains a substantial beneficial ownership.

Keywords

AbCellera Biologics, ABCL, Thermopylae Holdings, Form 4, Insider Transaction, Share Donation, Beneficial Ownership